A soluble form of CTLA-4 is present in paediatric patients with acute lymphoblastic leukaemia and correlates with CD1d+ expression.

CTLA-4 is a key factor in regulating and maintaining self tolerance, providing a negative signal to the T cell and thus limiting immune responses. Several polymorphisms within the CTLA-4 gene have been associated with an increased risk of developing autoimmune diseases and, very recently, with susce...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Rita Simone, Claudya Tenca, Franco Fais, Matteo Luciani, Giulio De Rossi, Giampaola Pesce, Marcello Bagnasco, Daniele Saverino
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2012
Materias:
R
Q
Acceso en línea:https://doaj.org/article/c72fbfdb2a4141708d5861e28637b799
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c72fbfdb2a4141708d5861e28637b799
record_format dspace
spelling oai:doaj.org-article:c72fbfdb2a4141708d5861e28637b7992021-11-18T08:14:15ZA soluble form of CTLA-4 is present in paediatric patients with acute lymphoblastic leukaemia and correlates with CD1d+ expression.1932-620310.1371/journal.pone.0044654https://doaj.org/article/c72fbfdb2a4141708d5861e28637b7992012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23049754/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203CTLA-4 is a key factor in regulating and maintaining self tolerance, providing a negative signal to the T cell and thus limiting immune responses. Several polymorphisms within the CTLA-4 gene have been associated with an increased risk of developing autoimmune diseases and, very recently, with susceptibility to human cancer. Acute lymphoblastic leukemia is a clonal disorder of lymphoid progenitors representing the most frequent malignancy of childhood. Here, we show the presence at significantly elevated levels of a circulating soluble form of CTLA-4 in 70% of B-ALL pediatric patients with active disease, the positive correlation between the percentage of leukemic B lymphocytes and the amount of serum sCTLA-4, and the expression of sCTLA-4 transcript by B cells in patients. Finally, a correlation between CD1d expression (a negative prognostic marker) and the sCTLA-4 in B-ALL patients was observed. This suggests a possible role of this soluble molecule as a marker of progression or severity of the neoplastic disease.Rita SimoneClaudya TencaFranco FaisMatteo LucianiGiulio De RossiGiampaola PesceMarcello BagnascoDaniele SaverinoPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 9, p e44654 (2012)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Rita Simone
Claudya Tenca
Franco Fais
Matteo Luciani
Giulio De Rossi
Giampaola Pesce
Marcello Bagnasco
Daniele Saverino
A soluble form of CTLA-4 is present in paediatric patients with acute lymphoblastic leukaemia and correlates with CD1d+ expression.
description CTLA-4 is a key factor in regulating and maintaining self tolerance, providing a negative signal to the T cell and thus limiting immune responses. Several polymorphisms within the CTLA-4 gene have been associated with an increased risk of developing autoimmune diseases and, very recently, with susceptibility to human cancer. Acute lymphoblastic leukemia is a clonal disorder of lymphoid progenitors representing the most frequent malignancy of childhood. Here, we show the presence at significantly elevated levels of a circulating soluble form of CTLA-4 in 70% of B-ALL pediatric patients with active disease, the positive correlation between the percentage of leukemic B lymphocytes and the amount of serum sCTLA-4, and the expression of sCTLA-4 transcript by B cells in patients. Finally, a correlation between CD1d expression (a negative prognostic marker) and the sCTLA-4 in B-ALL patients was observed. This suggests a possible role of this soluble molecule as a marker of progression or severity of the neoplastic disease.
format article
author Rita Simone
Claudya Tenca
Franco Fais
Matteo Luciani
Giulio De Rossi
Giampaola Pesce
Marcello Bagnasco
Daniele Saverino
author_facet Rita Simone
Claudya Tenca
Franco Fais
Matteo Luciani
Giulio De Rossi
Giampaola Pesce
Marcello Bagnasco
Daniele Saverino
author_sort Rita Simone
title A soluble form of CTLA-4 is present in paediatric patients with acute lymphoblastic leukaemia and correlates with CD1d+ expression.
title_short A soluble form of CTLA-4 is present in paediatric patients with acute lymphoblastic leukaemia and correlates with CD1d+ expression.
title_full A soluble form of CTLA-4 is present in paediatric patients with acute lymphoblastic leukaemia and correlates with CD1d+ expression.
title_fullStr A soluble form of CTLA-4 is present in paediatric patients with acute lymphoblastic leukaemia and correlates with CD1d+ expression.
title_full_unstemmed A soluble form of CTLA-4 is present in paediatric patients with acute lymphoblastic leukaemia and correlates with CD1d+ expression.
title_sort soluble form of ctla-4 is present in paediatric patients with acute lymphoblastic leukaemia and correlates with cd1d+ expression.
publisher Public Library of Science (PLoS)
publishDate 2012
url https://doaj.org/article/c72fbfdb2a4141708d5861e28637b799
work_keys_str_mv AT ritasimone asolubleformofctla4ispresentinpaediatricpatientswithacutelymphoblasticleukaemiaandcorrelateswithcd1dexpression
AT claudyatenca asolubleformofctla4ispresentinpaediatricpatientswithacutelymphoblasticleukaemiaandcorrelateswithcd1dexpression
AT francofais asolubleformofctla4ispresentinpaediatricpatientswithacutelymphoblasticleukaemiaandcorrelateswithcd1dexpression
AT matteoluciani asolubleformofctla4ispresentinpaediatricpatientswithacutelymphoblasticleukaemiaandcorrelateswithcd1dexpression
AT giulioderossi asolubleformofctla4ispresentinpaediatricpatientswithacutelymphoblasticleukaemiaandcorrelateswithcd1dexpression
AT giampaolapesce asolubleformofctla4ispresentinpaediatricpatientswithacutelymphoblasticleukaemiaandcorrelateswithcd1dexpression
AT marcellobagnasco asolubleformofctla4ispresentinpaediatricpatientswithacutelymphoblasticleukaemiaandcorrelateswithcd1dexpression
AT danielesaverino asolubleformofctla4ispresentinpaediatricpatientswithacutelymphoblasticleukaemiaandcorrelateswithcd1dexpression
AT ritasimone solubleformofctla4ispresentinpaediatricpatientswithacutelymphoblasticleukaemiaandcorrelateswithcd1dexpression
AT claudyatenca solubleformofctla4ispresentinpaediatricpatientswithacutelymphoblasticleukaemiaandcorrelateswithcd1dexpression
AT francofais solubleformofctla4ispresentinpaediatricpatientswithacutelymphoblasticleukaemiaandcorrelateswithcd1dexpression
AT matteoluciani solubleformofctla4ispresentinpaediatricpatientswithacutelymphoblasticleukaemiaandcorrelateswithcd1dexpression
AT giulioderossi solubleformofctla4ispresentinpaediatricpatientswithacutelymphoblasticleukaemiaandcorrelateswithcd1dexpression
AT giampaolapesce solubleformofctla4ispresentinpaediatricpatientswithacutelymphoblasticleukaemiaandcorrelateswithcd1dexpression
AT marcellobagnasco solubleformofctla4ispresentinpaediatricpatientswithacutelymphoblasticleukaemiaandcorrelateswithcd1dexpression
AT danielesaverino solubleformofctla4ispresentinpaediatricpatientswithacutelymphoblasticleukaemiaandcorrelateswithcd1dexpression
_version_ 1718422070961897472